Vaccine fra Janssen og Bavarian Nordic introduceres i Rwanda til at styrke beredskabet mod ebola
December 09, 2019 01:00 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 9. december 2019 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag at selskabets partner Janssen, datterselskab af Johnson & Johnson, vil donere op mod 200.000 doser af deres...
Vaccine Regimen from Janssen and Bavarian Nordic to Support Republic of Rwanda’s Preparedness Against Ebola Outbreak
December 09, 2019 01:00 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, December 9, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today announced, that its partner Janssen Pharmaceutical Companies of Johnson & Johnson will provide up to...
Bavarian Nordic A/S - Vedtægter
November 29, 2019 08:31 ET
|
Bavarian Nordic A/S
Opdaterede vedtægter for Bavarian Nordic A/S
Vedhæftet fil
Bavarian Nordic - Vedtægter
...
Bavarian Nordic A/S - Articles of Association
November 29, 2019 08:31 ET
|
Bavarian Nordic A/S
Updated Articles of Association for Bavarian Nordic A/S
Attachment
Bavarian Nordic - Articles of Association
...
Bavarian Nordic A/S – Orientering om forløb af ekstraordinær generalforsamling den 27. november 2019
November 27, 2019 10:13 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 27. november 2019 – Bavarian Nordic A/S (OMX: BAVA) har i dag afholdt ekstraordinær generalforsamling med følgende resultater: Bestyrelsen blev bemyndiget til i perioden indtil...
Bavarian Nordic A/S – Report on the Results of the Extraordinary General Meeting, held November 27, 2019
November 27, 2019 10:13 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, November 27, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) today held an Extraordinary General Meeting with the results as follows: The Board of Directors was authorized,...
Bavarian Nordic to Present at Jefferies 2019 London Healthcare Conference
November 15, 2019 08:00 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark – November 15, 2019 - Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that Paul Chaplin, President & CEO will provide a corporate presentation at the Jefferies...
Bavarian Nordic præsenterer på Jefferies 2019 London Healthcare Conference
November 15, 2019 08:00 ET
|
Bavarian Nordic A/S
KØBENHAVN, 15. november 2019 - Bavarian Nordic A/S (OMX: BAVA) deltager på Jefferies 2019 London Healthcare Conference, hvor administrerende direktør Paul Chaplin vil præsentere selskabet på torsdag...
Phase 3 Results of Bavarian Nordic’s Smallpox Vaccine Published in The New England Journal of Medicine
November 14, 2019 02:23 ET
|
Bavarian Nordic A/S
COPENHAGEN, Denmark, November 14, 2019 – Bavarian Nordic A/S (OMX: BAVA, OTC: BVNRY) announced today that results from the pivotal Phase 3 efficacy trial of its smallpox vaccine, MVA-BN®, have been...
Fase 3 resultater for Bavarian Nordics koppevaccine er optaget i The New England Journal of Medicine
November 14, 2019 02:23 ET
|
Bavarian Nordic A/S
KØBENHAVN, Danmark, 14. november 2019 – Bavarian Nordic A/S (OMX: BAVA) meddelte i dag, at resultater fra det afgørende fase 3-effektforsøg med selskabets koppevaccine, MVA-BN®, er blevet...